Keros Therapeutics shares owned by Candriam Luxembourg S.C.A.
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Candriam Luxembourg S.C.A.
from 13F filings
Historical chart of Candriam Luxembourg S.C.A. investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Keros Therapeutics by Candriam Luxembourg S.C.A.
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $20M | 442k | 45.70 |
2024-03-31 | $43M | 652k | 66.20 |
2023-12-31 | $33M | 819k | 39.76 |
2023-09-30 | $24M | 741k | 31.87 |
2023-06-30 | $29M | 721k | 40.20 |
2023-03-31 | $32M | 745k | 42.70 |
2022-12-31 | $30M | 626k | 48.00 |
2022-09-30 | $14M | 362k | 37.62 |
2022-06-30 | $0 | 362k | 0.00 |
2022-03-31 | $23M | 421k | 54.38 |
2021-12-31 | $14M | 241k | 58.51 |
2021-09-30 | $9.5M | 241k | 39.56 |
2021-06-30 | $4.3M | 101k | 42.47 |
More positions owned by Candriam Luxembourg S.C.A.
View all positions for Candriam Luxembourg S.C.A.